InsidersTradesSigma
Track the MACROGENICS INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Jeffrey Peters. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
MACROGENICS INC. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It is listed on NASDAQ under the ticker MGNX.